Overview
What is Alzheimer's Drug Discovery Foundation?
The Alzheimer's Drug Discovery Foundation is a New York-based nonprofit organization, located at 57 West 57th Street, dedicated to expediting the discovery of drugs to prevent, treat, and ultimately cure Alzheimer's disease and related dementias. With a mission to accelerate research in academia and the biotech industry, the Alzheimer's Drug Discovery Foundation employs a venture philanthropy model, focusing solely on funding the development of drugs for Alzheimer's. Their team comprises 41 individuals, all committed to making a significant impact on the lives of those affected by these debilitating conditions.
Official website here: www.alzdiscovery.org
What are the reviews and ratings of this charity?
Charity Navigator Rating 97%
The Alzheimer's Drug Discovery Foundation receives a Four-Star out of Four Star rating from Charity Navigator, reflecting its strong performance in accountability and finance, as well as its organizational integrity. With a notable score of 97%, it highlights the foundation's commitment to transparency, ethical governance, and efficient use of funds, with 98.5% of its expenses going directly towards its programs.
The foundation boasts a fully independent board, with 100% of its members being independent, ensuring unbiased decision-making. It has implemented robust policies regarding conflict of interest, whistleblower protections, and document retention, which further enhance its credibility. Additionally, its financial health is commendable, with a low liabilities-to-assets ratio and a strong working capital ratio that demonstrates sustainability.
User feedback underscores the foundation's effective approach to funding Alzheimer’s research, earning it commendations for its focus on innovative therapies. While the data shows exceptionally positive ratings and a solid financial framework, ongoing community engagement and outreach could enhance its visibility and impact further. Overall, the foundation is well-regarded within the nonprofit sector for its dedication to advancing Alzheimer's research.
This AI summary has been generated from information found on Charity Navigator.
Is Alzheimer's Drug Discovery Foundation legitimate?
Alzheimer's Drug Discovery Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. Alzheimer's Drug Discovery Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $1,873,002
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,421,825
For more financial information, click here
Official website here: www.alzdiscovery.org
What is the mission statement of Alzheimer's Drug Discovery Foundation?
The Alzheimer's Drug Discovery Foundation is committed to expediting the discovery of drugs to prevent, treat, and potentially cure Alzheimer's disease and related dementias. This foundation's mission is to make a significant impact on the development of drugs for Alzheimer's, employing a venture philanthropy model to support research in both academic institutions and the biotech industry. The Alzheimer's Drug Discovery Foundation's primary focus is on accelerating the drug discovery process to combat these debilitating conditions.
Official website here: www.alzdiscovery.org
Who is the CEO of Alzheimer's Drug Discovery Foundation?
Howard Fillit Md is the Governor of Alzheimer's Drug Discovery Foundation. The CEO's salary of Alzheimer's Drug Discovery Foundation is $536,310 and their total compensation is $573,133.
Official website here: www.alzdiscovery.org
What is the revenue of Alzheimer's Drug Discovery Foundation?
Alzheimer's Drug Discovery Foundation's revenue in 2022 was $254,027,105.
Official website here: www.alzdiscovery.org
Who are the executives of Alzheimer's Drug Discovery Foundation and what are their salaries?
The average compensation at Alzheimer's Drug Discovery Foundation during 2022 was $80,362. There are 41 employees and 23 volunteers at Alzheimer's Drug Discovery Foundation.
Here are 31 key members and their salaries (Alzheimer's Drug Discovery Foundation's CEO's salary is $536,310 and their total compensation is $573,133):
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $593,893
- Related: $0
- Other: $26,486
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $309,162
- Related: $0
- Other: $22,653
- Compensation: $536,310
- Related: $0
- Other: $36,823
- Compensation: $309,720
- Related: $0
- Other: $0
- Compensation: $169,733
- Related: $0
- Other: $11,719
- Compensation: $430,343
- Related: $0
- Other: $22,838
- Compensation: $165,171
- Related: $0
- Other: $19,580
- Compensation: $171,406
- Related: $0
- Other: $19,200
Official website here: www.alzdiscovery.org
Where can I find the form 990 for Alzheimer's Drug Discovery Foundation?
Alzheimer's Drug Discovery Foundation's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.alzdiscovery.org
Learn more at the official website: www.alzdiscovery.org
Mission Statement of Alzheimer's Drug Discovery Foundation
The Alzheimer's Drug Discovery Foundation (ADDF) is a leading organization relentlessly driving the discovery of novel drugs to prevent, treat, and ultimately cure Alzheimer's disease and related dementias. This nonprofit entity is committed to swiftly advancing research in academia and the biotech industry, employing a venture philanthropy approach to fund drug development efforts.
With unwavering focus, ADDF aims to bring about breakthroughs in the field, as the quest for effective treatments and a cure for Alzheimer's remains an urgent priority. By investing in cutting-edge research, the organization supports the development of promising therapeutics that hold the potential to transform the lives of those affected by these devastating conditions.
Leveraging its unique venture philanthropy model, ADDF collaborates with researchers and scientific teams to accelerate the drug discovery process, providing vital funding and resources to bring potential therapies to fruition. The foundation's mission is not simply to fund research but also to actively engage with the scientific community to ensure the most promising drug candidates progress through the development pipeline. In doing so, ADDF plays an essential role in bringing hope to millions of individuals and families impacted by Alzheimer's disease and related dementias.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Alzheimer's Drug Discovery Foundation (ADDF) significantly impacts the fight against Alzheimer's disease and related dementias by accelerating the discovery of effective treatments and preventive measures. By employing a venture philanthropy model, the ADDF strategically funds innovative research in both academic and biotech sectors, fostering collaborations that drive the development of new drugs. Their focused approach has not only advanced scientific understanding but also supported a pipeline of potential therapies, thereby offering hope to millions affected by these debilitating conditions. Through its efforts, the ADDF plays a crucial role in the broader mission to treat and eventually cure Alzheimer's disease, making strides toward a future with improved care and outcomes for patients and their families.
This information is meant to be a general summary of Alzheimer's Drug Discovery Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: -$2,054,312
- Program Service Revenue: $6,425,669
- Gross Receipts: $562,241,036
Assets and Liabilities:
- Total Assets: $340,253,841
- Total Liabilities: $56,741,667
- Net Assets: $283,512,174
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PRI INCOME
Revenue
$6,415,669
CONFERENCE REG. FEES
Revenue
$10,000
Organization Details
Founding Year
2004
Phone
(212) 901-8000Principal Officer
Howard Fillit Md
Main Address
57 WEST 57TH ST 904, NEW YORK, NY, 10019
Website
www.alzdiscovery.orgNTEE Category
Code: V36 - Social research
If you are a representative of Alzheimer's Drug Discovery Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.